CervicaDx (HPV Profiler)

About Predica Diagnostics

Predica Diagnostics is an early-stage diagnostics company leveraging its proprietary ciRNAseq technology to develop non-invasive tests for cancer. Its lead program, CervicaDx, aims to improve cervical cancer screening by identifying high-risk lesions with higher specificity, thereby reducing unnecessary procedures. The company has established key partnerships, secured intellectual property, and is actively engaged in product development and validation. Predica operates as a private, pre-revenue entity with a small, specialized team driving its research and business strategy.

Therapeutic Areas